Realtime | Geld | Brief | Zeit |
---|---|---|---|
5,158 | 5,508 | 19.07. |
Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
Mo | XFRA NEW INSTRUMENTS AVAILABLE ON 14.07.2025 | 214 | Xetra Newsboard | The following instruments on XETRA do have their first trading 14.07.2025 Die folgenden Instrumente in XETRA haben ihren ersten Handelstag 14.07.2025
Aktien
1 PLK2ITR00010 Fabrity S.A.
2 SE0013512506... ► Artikel lesen | |
Q-LINEA Aktie jetzt für 0€ handeln | |||||
11.07. | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 11.07.2025 | 400 | Xetra Newsboard | The following instruments on Boerse Frankfurt do have their last trading day on 11.07.2025Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 11.07.2025ISIN NameCA1394811055 CAPE... ► Artikel lesen | |
11.07. | XFRA ISIN CHANGE | 170 | Xetra Newsboard | Einstellung Aufnahme ISIN Name Einstellung mit Ablauf: ISIN Name Ab dem: AnmerkungenUS52110H1005 Lazydays Holdings Inc. 11.07.2025 US52110H2094 Lazydays Holdings Inc. 14.07.2025 Tausch 30:1US08862L1035 Beyond... ► Artikel lesen | |
11.07. | XFRA CAPITAL ADJUSTMENT INFORMATION - 11.07.2025 | 172 | Xetra Newsboard | Das Instrument 7HW SE0015812516 WYLD NETWORKS AB EQUITY wird cum Kapitalmassnahme gehandelt am 11.07.2025 und ex Kapitalmassnahme am 14.07.2025 The instrument 7HW SE0015812516 WYLD NETWORKS AB EQUITY... ► Artikel lesen | |
10.07. | Q-Linea AB: Interim report 1 January - 30 June 2025 | 101 | GlobeNewswire (Europe) | Mid-year performance on track for 2025 plan
The quarter April - June 2025Net sales amounted to SEK 1.1 (0.2) million.Operating result (EBIT) of SEK -47.3 (-65.3) million.Profit after tax amounted to... ► Artikel lesen | |
09.07. | Split and Change of ISIN for Q-Linea AB | 141 | GlobeNewswire | The company will carry out a reverse stock split in relations 1:1000. The share will be traded under new ISIN code with effect from July 14, 2025. The order book will not change.
Short... ► Artikel lesen | |
08.07. | Q-Linea AB: Q-linea AB announces timetable for reverse share split | 159 | GlobeNewswire (Europe) | At the annual general meeting of Q-linea AB (publ) (the "Company") on 26 June 2025, it was resolved to carry out a reverse share split of 1:1000, entailing that one thousand (1000) shares will be combined... ► Artikel lesen | |
19.06. | Q-Linea AB: Q-linea on track for 2025 plan | 357 | GlobeNewswire (Europe) | Q-linea AB (publ) (OMX: QLINEA) today shared a Company and Market update.
Key messagesQ2 instrument placements: Five newly-contracted units were placed, bringing the total to 14 YTD (2024: 4, Q1 2025:... ► Artikel lesen | |
23.05. | Q-Linea AB: Q-linea's board of directors proposes a reverse share split and a reduction of the share capital | 197 | GlobeNewswire (Europe) | The board of directors of Q-linea AB (publ) ("Q-linea" or the "Company") (Nasdaq Stockholm: QLINEA) proposes that the annual general meeting on 26 June 2025 resolves on a reverse share split where 1... ► Artikel lesen | |
14.04. | Q-Linea AB: Interim report 1 January - 31 March 2025 | 251 | GlobeNewswire (Europe) | Strong start to the year with accelerating momentum
First quarter: 1 January-31 March 2025Five customer contracts were signed during the quarter, three of which were in the US.Total of 9 ASTar units... ► Artikel lesen | |
25.03. | Q-Linea AB: Q-linea announces tender win in Italy | 216 | GlobeNewswire (Europe) | Q-linea AB (publ) (OMX: QLINEA) today announces the awarding of a rapid AST tender for the Naples region.
Q-linea's ASTar® platform has been selected to provide rapid AST for a network of hospitals... ► Artikel lesen | |
18.03. | Q-Linea AB: Q-linea anticipates accelerating ASTar placements through 2025 and 2026 driving revenue growth | 329 | GlobeNewswire (Europe) | Q-linea AB (publ) (OMX: QLINEA) today shared a Company and Market update.
Key messagesAnticipate total contracts for 30 - 40 ASTar instruments by end-2025; roughly 50% in USAdditional placements of... ► Artikel lesen | |
28.02. | Q-Linea AB: Year-end report 1 January - 31 December 2024 | 247 | GlobeNewswire (Europe) | Rights issue of SEK 225 million
Fourth quarter: 1 October - 31 December 2024Net sales amounted to SEK 0.2 million (0.1).The operating result totalled SEK -51.3 million (-55.4).The result for the period... ► Artikel lesen | |
05.02. | Q-Linea AB: Q-linea awarded first public tender in Belgium | 305 | GlobeNewswire (Europe) | Q-linea AB (publ) (OMX: QLINEA) today announces that the company has been awarded the tender at Cliniques Universitaires Saint-Luc in Brussels, Belgium for the ASTar® Instrument and Consumables through... ► Artikel lesen | |
31.01. | Q-Linea AB: Q-linea announces preliminary outcome of the rights issue | 580 | GlobeNewswire (Europe) | Q-linea AB (publ) ("Q-linea" or the "Company") (Nasdaq Stockholm: QLINEA) announces the preliminary outcome of the Company's rights issue of approximately SEK 225 (the "Rights Issue"), for which the... ► Artikel lesen | |
24.01. | Q-Linea AB: Continued commercial progress with US reference laboratory | 756 | GlobeNewswire (Europe) | Q-linea AB (publ) (OMX: QLINEA) today announces contract negotiations continue between Q-linea, Inc. and a large US reference laboratory, with an agreement anticipated in February 2025.
Initial sites... ► Artikel lesen | |
10.01. | XFRA CAPITAL ADJUSTMENT INFORMATION - 10.01.2025 | 654 | Xetra Newsboard | Das Instrument FQ1 KYG8656L1068 TH INTL LTD DL-,0001 EQUITY wird cum Kapitalmassnahme gehandelt am 10.01.2025 und ex Kapitalmassnahme am 13.01.2025 The instrument FQ1 KYG8656L1068 TH INTL LTD DL-,0001... ► Artikel lesen | |
03.01. | Q-linea AB: Q-linea resolves on the terms for a rights issue of approximately SEK 225 million | 745 | GlobeNewswire (Europe) | Q-linea AB (publ) ("Q-linea" or the "Company") announces that the board of directors today has resolved on the terms for the planned rights issue of units with preferential rights for the Company's... ► Artikel lesen | |
05.11.24 | Q-linea AB: Interim report 1 January - 30 September 2024 | 241 | GlobeNewswire (Europe) | Growing pipeline in the US
Third quarter: 1 July - 30 September 2024Net sales amounted to SEK 0.6 million (3.0).The operating result totalled SEK -41.1 million (-48.2).The result for the period amounted... ► Artikel lesen |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
FRESENIUS | 40,890 | -0,87 % | Aktie von Fresenius SE & Co. KGaA heute am Aktienmarkt kaum gefragt: Kurs fällt (41,21 €) | An der deutschen Börse notiert die Fresenius SE & Co. KGaA-Aktie derzeit ein wenig leichter. Die Aktie notiert zur Stunde bei 41,21 Euro. Der Anteilsschein von Fresenius+Co KgaA verzeichnet aktuell... ► Artikel lesen | |
FRESENIUS MEDICAL CARE | 45,940 | -1,40 % | DAX tiefer, Bitcoin, Silber stark: BASF, Lufthansa, BMW, Rheinmetall, FMC, Siemens Energy ... | Die Ankündigung von Donald Trump, Importe aus der EU ab 1. August mit einem Zoll in Höhe von 30 Prozent belegen zu wollen, hat beim DAX am Freitag Bremsspuren hinterlassen. Der deutsche Leitindex verabschiedete... ► Artikel lesen | |
CARL ZEISS MEDITEC | 51,70 | +1,47 % | ANALYSE-FLASH: RBC lässt Carl Zeiss Meditec auf 'Sector Perform' - Ziel 60 Euro | NEW YORK (dpa-AFX) - Die kanadische Bank RBC hat die Einstufung für Carl Zeiss Meditec mit einem Kursziel von 60 Euro auf "Sector Perform" belassen. Analyst Jack Reynolds-Clark sieht laut seinem am... ► Artikel lesen | |
DRAEGERWERK | 70,10 | +2,49 % | DAX-Check LIVE: BASF, Brenntag, Commerzbank, Drägerwerk, Mutares, Renk, Thyssenkrupp im Fokus | Der DAX schloss vor dem Wochenende mit einem Rückgang von 0,8 Prozent bei 24.255 Punkten. Trotz dieses Rücksetzers verzeichnete der deutsche Leitindex auf Wochensicht weiterhin ein Plus von zwei Prozent.... ► Artikel lesen | |
MEDTRONIC | 77,05 | -0,09 % | Medtronic Begins U.S. Trial Of Onyx LES For Peripheral Arterial Hemorrhage | DUBLIN (dpa-AFX) - Medtronic (MDT) has announced the enrollment of the first patient in its PELE (PEripheral Onyx Liquid Embolic) clinical trial, which will evaluate the safety and efficacy... ► Artikel lesen | |
INTUITIVE SURGICAL | 444,50 | -0,37 % | Intuitive Surgical, Inc.: Intuitive demonstrates telesurgery capabilities | SUNNYVALE, Calif., July 16, 2025 (GLOBE NEWSWIRE) -- Intuitive (NASDAQ:ISRG), a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, has today demonstrated... ► Artikel lesen | |
TELADOC HEALTH | 6,912 | -0,27 % | Teladoc launches Wellbound, an employee assistance program that leverages BetterHelp | ||
THERMO FISHER | 355,20 | -0,43 % | Thermo Fisher übernimmt Sterilproduktion von Sanofi in den USA | Der US-Laborausrüster Thermo Fisher Scientific erweitert seine Produktionsinfrastruktur und übernimmt die Sterilfabrik von Sanofi im US-Bundesstaat New Jersey. Das Werk in Ridgefield soll künftig das... ► Artikel lesen | |
ROKU | 80,20 | -0,09 % | Roku Set For Q2 Spotlight As Ad Resilience, Frndly Boost, Amazon Deal Fuel Investor Optimism | ||
HIMS & HERS HEALTH | 43,220 | -0,25 % | Hims & Hers nach Aus mit Novo Nordisk: "Erhöhtes Risiko von Rechtsstreitigkeiten" | Wie gewonnen, so zerronnen: Zunächst entfachte die umfangreiche Zusammenarbeit zwischen dem Telehealth-Unternehmen Hims & Hers und dem Biopharma-Riesen Novo Nordisk jede Menge Euphorie. Doch dann kam... ► Artikel lesen | |
SERNOVA BIOTHERAPEUTICS | 0,108 | +4,85 % | Sernova Biotherapeutics, Inc.: Sernova Biotherapeutics Announces Collaboration with Eledon Pharmaceuticals to Advance a Potential Functional Cure for Type 1 Diabetes | LONDON, Ontario, July 09, 2025 (GLOBE NEWSWIRE) -- Sernova Biotherapeutics ("Sernova") (TSX: SVA) (OTCQB: SEOVF) (FSE/XETRA: PSH) today announced a Collaborative Research Agreement with Eledon Pharmaceuticals... ► Artikel lesen | |
DEXCOM | 71,80 | -0,51 % | FDA announces recall of certain Dexcom glucose monitoring devices | ||
ALCON | 75,00 | -0,32 % | Alcon's Unity VCS Gets Health Canada Approval | OTTAWA (dpa-AFX) - Alcon, Inc. (ALC) announced Tuesday that UNITY Vitreoretinal Cataract System (VCS) has received Health Canada approval. This innovation is the first to be introduced from... ► Artikel lesen | |
NUGEN MEDICAL DEVICES | 0,034 | -5,59 % | Beaking News: Vive la InsuJet - mit der Krankenkasse zum Erfolg? | ||
SIEMENS HEALTHINEERS | 46,110 | -1,03 % | BASF schraubt Erwartungen zurück, Brenntag wird ebenfalls vorsichtiger, Covestro reiht sich ein und Siemens Healthineers leidet unter Zollsorgen | Einmal mehr sorgt US-Präsident Donald Trump mit diversen Zolldrohungen für Verunsicherung an der Börse. Der EU werden ab August pauschal 30 Prozent für sämtliche Exporte in die USA in Aussicht gestellt... ► Artikel lesen |